Blache, Ulrich http://orcid.org/0000-0003-4233-2268
Popp, Georg
Dünkel, Anna
Koehl, Ulrike
Fricke, Stephan
Funding for this research was provided by:
Fraunhofer Organization | Fraunhofer-Institut für Zelltherapie und Immunologie
Bundesministerium für Bildung und Forschung (03ZU1111NA)
Article History
Received: 16 May 2022
Accepted: 19 August 2022
First Online: 5 September 2022
Competing interests
: U.K. is a consultant in immuno-oncology for AstraZeneca, Affimed, Glycostem, GammaDelta and Zelluna. S.F. is a consultant for Janssen-Cilag. All authors are involved in collaborations with Novartis and Miltenyi Biotec regarding the production of CAR T cells. All authors declare no other competing interests.